CareFusion Acquires Surgical Site Solutions to Expand Surgical Clipper Offering

ClipVac Helps Improve Pre-Surgical Hair Removal Practice

Feb 10, 2015

SAN DIEGO, CA, February 10, 2015 – CareFusion (NYSE:CFN), a leading global medical technology company, today announced it has acquired Surgical Site Solutions, Inc. to expand its surgical clipper portfolio with the ClipVac pre-surgical hair removal system.

The ClipVac system is designed to improve the current hair removal practice by vacuum capturing hair clippings at the source. As an attachment to CareFusion Surgical Clippers, the ClipVac system saves time by capturing 98.5 percent of hair and airborne contaminants at the source, reducing the need for a secondary process of clean up. Test data supports vacuum technology as a safe, highly effective and efficient alternative when hair removal is carried out in the surgical or ancillary setting.

“We have had a close relationship with Surgical Site Solutions during an exclusive and successful collaboration with the ClipVac system and our surgical clippers,” said Jan Creidenberg, vice president and general manager of Infection Prevention for CareFusion. “Bringing this proprietary technology into the CareFusion surgical clipper portfolio fits our strategy to help customers improve efficiency and patient safety in the clinical setting. We were also pleased with the market acceptance of the ClipVac technology along with CareFusion Clippers during our initial collaboration."

Terms of the agreement were not disclosed.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 65,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to healthcare. In 2017, BD welcomed C. R. Bard and its products into the BD family. For more information on BD, please visit bd.com

For more information on BD, please visit bd.com.

Troy Kirkpatrick

858 617 2361
Email Troy

Back to News Releases